期刊文献+

机械取栓联合动脉溶栓对缺血性脑卒中患者的疗效及神经功能的影响

Effects of Mechanical Thrombus Removal Combined with Arterial Thrombolysis on Patients with Ischemic Cerebrovascular Disease And Its Influence on Nerve Function
原文传递
导出
摘要 目的探讨机械取栓联合动脉溶栓对缺血性脑卒中患者的疗效及神经功能的影响。方法选取2016年3月至2021年4月于阳江市人民医院治疗的缺血性脑卒中患者56例作为研究对象,按治疗方法不同分为观察组与对照组,各28例。观察组采用机械取栓联合动脉溶栓治疗,对照组采用静脉溶栓治疗。治疗后3周采用美国国立卫生研究院卒中量表(NIHSS)对两组患者疗效进行评估,并比较两组患者治疗前及治疗后24 h、3 d、3周的NIHSS评分,比较治疗后两组患者血管再通情况和预后情况。结果观察组治疗有效率(92.86%)高于对照组(71.43%)(P<0.05)。治疗后24 h、3 d、3周两组患者NIHSS评分较治疗前降低,且随着治疗时间的推移NIHSS评分逐渐降低,差异有统计学意义(P<0.05);且观察组治疗后24 h、3 d、3周NIHSS评分与对照组相同时间比较降低,差异有统计学意义(P<0.05)。治疗3周后,观察组血管再通率(89.29%)高于对照组(71.43%)(P<0.05)。两组患者不良反应发生率比较,差异无统计学意义(P>0.05),观察组复发率和死亡率低于对照组,但差异无统计学意义(P>0.05)。结论机械取栓联合动脉溶栓治疗缺血性脑卒中可提高临床效果,促进患者神经功能恢复。 Objective To investigate the effects of mechanical thrombus removal combined with arterial thrombolysis in the treatment of ischemic cerebrovascular disease and its influence on nerve function. Methods A total of 56 patients with ischemic stroke treated in Yangjiang People’s Hospital from March 2016 to April 2021 were selected as the research objects, and were divided into an observation group and a control group according to different treatment methods, with 28 patients in each group. The observation group was treated with mechanical thrombectomy combined with arterial thrombolysis, and the control group was treated with intravenous thrombolysis. National Institutes of Health Stroke Scale(NIHSS) was used to evaluate the efficacy of the two groups 3 weeks after treatment, and NIHSS scores were compared between the two groups before treatment and 24 h, 3 d and 3 weeks after treatment, and vascular recanalization and prognosis were compared between the two groups after treatment. Results The effective rate of observation group(92.86%) was higher than that of control group(71.43%)(P<0.05). NIHSS scores of the two groups were lower than before 24 h, 3 d and 3 weeks after treatment, and gradually decreased with the passage of treatment time, with statistical significance(P<0.05). The NIHSS score of the observation group was lower than that of the control group at 24 h, 3 d and 3 weeks after treatment,and the difference was statistically significant(P<0.05). After 3 weeks of treatment, the vascular recanalization rate in the observation group(89.29%) was higher than that in the control group(71.43%)(P<0.05). There was no statistical significance in the incidence of adverse reactions between 2 groups(P>0.05), and the recurrence rate and mortality rate in observation group were lower than those in control group, but the difference was not statistically significant(P>0.05). Conclusion Mechanical thrombectomy combined with arterial thrombolysis in the treatment of ischemic stroke can improve the clinical effect and promote the recovery of nerve function.
作者 陈志健 林涛 文学 罗德宏 陈志强 CHENZhi-Jian;LIN Tao;WEN Xue;LUO De-Hong;CHEN Zhi-Qiang(Department of Neurology,Yangjiang People's Hospital,Yangjiang 529500,China)
出处 《中国药物经济学》 2022年第4期86-89,共4页 China Journal of Pharmaceutical Economics
关键词 机械取栓 动脉溶栓 静脉溶栓 缺血性脑卒中 神经功能 Mechanical thrombus removal Arterial thrombolysis Intravenous thrombolysis Ischemic cerebrovascular disease Nerve function
  • 相关文献

参考文献8

二级参考文献137

  • 1丁宏岩,董强.基底动脉梗死的治疗:动脉和静脉溶栓效果比较的系统分析[J].中国卒中杂志,2006,1(6):414-416. 被引量:127
  • 2李剑鹏,马琪林,童绥君,曲红丽,鲁丛霞,黄远亮.颈内动脉系统脑梗死3~6h静脉溶栓与动脉溶栓的比较[J].中国实用神经疾病杂志,2010,13(23):3-6. 被引量:7
  • 3Wahlgren N, Ahrced N, Davalos A, et al; SITS-MOST Investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITSMOST): an observational study. Lancet, 2007, 369: 275-282.
  • 4Lyden PD, ed. Thrombolytic Therapy for Acute Stroke. 2nd ed. Totowa, NJ: Hmreana Press, 2005.
  • 5Wardlaw JM, Smdercock PA, Berg: E. Throrrbolytic therapy with recoinbinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cunaflative meta-analysis. Stroke, 2003, 34: 1437-1442.
  • 6Wardlaw JM, Zoppo G, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev, 2003, (4): CD000213.
  • 7Shanna M, Clark H, Armour T, et al. Acute stroke: evaluation and treatment. Evid Rep Technol Assess (Sunmm), 2005, (127): 1-7.
  • 8Hill MD, Buchan AM; Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Throrrbolysis for acute ischemic stroke: results of the Canadian Altephse for Stroke Effectiveness Study. CMAJ, 20(0, 172: 1307-1312.
  • 9Chung H, Refoios Canto R, Canto RR, et al. Alteplase for the treatment of acute ischaemic stroke: NICE technology appraisal guidance. Heart, 2007, 93: 1616-1617.
  • 10Saver JL, Smith EE, Fonarow GC, et al; GWTG-stroke Steering Committee and Investigators. The "golden hour" and acute brain ischemia: presenting features and lytic therapy in > 30,000 patients ariving within 60 minutes of stroke onset. Stroke, 2010, 41: 1431-1439.

共引文献1063

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部